Literature DB >> 11168806

Isoform-selective upregulation of mast cell chymase in the development of skin fibrosis in scleroderma model mice.

E Kakizoe1, N Shiota, Y Tanabe, K Shimoura, Y Kobayashi, H Okunishi.   

Abstract

The involvement of connective-tissue-type mast cells and chymase, a protease unique to their secretory granules, has been implicated in fibrotic diseases. To elucidate the role of chymase in fibroproliferative inflammation, in this study we examined the enzymatic activity and mRNA expression of chymase in the sclerotic skin of tight-skin mice; syngeneic Pallid mice served as the control. Dorsal skin specimens from mice aged 5, 10, and 20 wk were evaluated by morphometric and biochemical analyses. At ages 10 and 20 wk, the hydroxyproline concentration in tight-skin dermis was higher than that in Pallid. At any age, the subcutaneous fibrous layer was thicker in tight-skin than in Pallid. In accordance with these fibrous changes, both connective-tissue-type mast cell counts and chymase activity were higher in tight-skin skin than in Pallid skin up to 20 wk of age. Age-matched (10-wk-old) tight-skin and Pallid were quantified for their mRNA of connective-tissue-type mast-cell-specific chymase, mouse mast cell protease-4, by the competitive reverse transcriptase polymerase chain reaction technique, which revealed its higher level in tight-skin than Pallid. In contrast, the mRNA level of mouse mast cell protease-5, the chymase isoform of undifferentiated mast cells, in tight-skin skin was only a tenth that of mouse mast cell protease-4 and no different from the mouse mast cell protease-5 mRNA level of Pallid mice. An in situ hybridization study confirmed the higher expression of mouse mast cell protease-4 by connective-tissue-type mast cells in tight-skin skin than Pallid skin. These results strongly support the contention that the connective-tissue-type mast cell chymase plays a crucial role in fibroproliferative remodeling of the skin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11168806     DOI: 10.1046/j.1523-1747.2001.00165.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  6 in total

Review 1.  Novel Insight into the in vivo Function of Mast Cell Chymase: Lessons from Knockouts and Inhibitors.

Authors:  Gunnar Pejler
Journal:  J Innate Immun       Date:  2020-06-04       Impact factor: 7.349

2.  Effect of mast cell chymase inhibitor on the development of scleroderma in tight-skin mice.

Authors:  Naotaka Shiota; Eiichi Kakizoe; Keiko Shimoura; Tetsuya Tanaka; Hideki Okunishi
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

3.  Role of mast cells, stem cell factor and protease-activated receptor-2 in tubulointerstitial lesions in IgA nephropathy.

Authors:  Hong Liu; Fuyou Liu; Youming Peng; Yinghong Liu; Lingyan Li; Xiwen Tu; Meichu Cheng; Xiangqing Xu; Xing Chen; Guanghui Ling; Lin Sun
Journal:  Inflamm Res       Date:  2010-02-04       Impact factor: 4.575

4.  The anti-allergic compound tranilast attenuates inflammation and inhibits bone destruction in collagen-induced arthritis in mice.

Authors:  N Shiota; P T Kovanen; K K Eklund; N Shibata; K Shimoura; T Niibayashi; C Shimbori; H Okunishi
Journal:  Br J Pharmacol       Date:  2010-01-08       Impact factor: 8.739

5.  The role of macrophage migration inhibitory factor in mast cell-stimulated fibroblast proliferation and collagen production.

Authors:  Gu Ningyan; Yao Xu; Shi Hongfei; Chen Jingjing; Chen Min
Journal:  PLoS One       Date:  2015-03-31       Impact factor: 3.240

Review 6.  A Review of the Evidence for and against a Role for Mast Cells in Cutaneous Scarring and Fibrosis.

Authors:  Traci A Wilgus; Sara Ud-Din; Ardeshir Bayat
Journal:  Int J Mol Sci       Date:  2020-12-18       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.